Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?

Among 275 patients with COVID-19, we found that median blood zinc level was significantly lower in patients with poor clinical outcome (N = 75) as compared to patients with good clinical outcome (N = 200) (840 μg/L versus 970 μg/L; p < 0.0001), suggesting that zinc supplementation could be useful...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubourg, Grégory, Lagier, Jean-Christophe, Brouqui, Philippe, Casalta, Jean-Paul, Jacomo, Véronique, La Scola, Bernard, Rolain, Jean-Marc, Raoult, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881284/
https://www.ncbi.nlm.nih.gov/pubmed/33632620
http://dx.doi.org/10.1016/j.jmii.2021.01.012
Descripción
Sumario:Among 275 patients with COVID-19, we found that median blood zinc level was significantly lower in patients with poor clinical outcome (N = 75) as compared to patients with good clinical outcome (N = 200) (840 μg/L versus 970 μg/L; p < 0.0001), suggesting that zinc supplementation could be useful for patients with severe COVID-19.

Ejemplares similares